Maximum quantity allowed is 999
请选择数量
CAS RN: 1431-39-6 | 產品號碼: D5405
Dansylamide [for Albumin binding assay]
×
![]()
×
![Dansylamide [for Albumin binding assay]](/_ui/responsive/theme-tci/images/missing_product_zoom.jpg "Dansylamide [for Albumin binding assay]")
| 包裝 | 價格 | 同一天 | 2-3个工作日 |
|---|---|---|---|
| 25MG |
NT$2,000
|
1 | 聯繫我們 |
| 100MG |
NT$6,000
|
9 | 5 |
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準，敬請留意。
| 產品號碼 | D5405 |
| 純度/分析方法 | >98.0%(T) |
| 分子式 / 分子量 | C__1__2H__1__4N__2O__2S = 250.32 |
| 外觀與形狀（20°C） | Solid |
| 儲存條件 | Room Temperature (Recommended in a cool and dark place, <15°C) |
| 應避免的情況 | Light Sensitive |
| 包裝和容器 | 100MG-Glass Bottle with Plastic Insert （閲覽圖片）, 25MG-Glass Bottle with Plastic Insert （閲覽圖片） |
| CAS RN | 1431-39-6 |
| Reaxys-RN | 2217203 |
| PubChem Substance ID | 354335223 |
| SDBS (AIST Spectral DB) | 11148 |
| MDL編號 | MFCD00004000 |
產品規格
| Appearance | White to Light yellow powder to crystal |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Melting point | 218.0 to 222.0 °C |
| Human serum albmin (HSA) binding activity | S/N ratio min. 4 |
| Competitive avtivity in competitive drug | Remaining fluorescein inensity max. 70 % |
| Non-competitive avtivity in non-competitive drug | Remaining fluoresein intensity min. 80 % |
性質
| 熔點 | 219 °C |
| 溶解性（可溶於） | Dimethylformamide |
GHS
相關法規
運輸資料
| HS編碼* | 2935.90-000 |
Application
Fluorescent Probes for the Characterization of Two Specific Drug Binding Sites on HSA
Human Serum Albumin (HSA) binds to a wide variety of drugs at two primary binding sites (I: blue and II: yellow), and can have a significant impact on their pharmacokinetics and pharmacological effects. The fluorescent probes, dansylamide (1) and dansylglycine (2) selectively interact with sites I and II, respectively.1,2) BD140 (3) also binds to drug binding site II specifically.3) Changes in probe fluorescence are analyzed by fluorescence titrations as a result of competitive displacient by drugs and pharmaceuticals. The pattern of fluorescent probe displacient by these reagents enabled the identification of two specific drug binding sites, which illustrates their usefulness for the characterization of the binding sites in HSA.
References
- 1)The Characterization of Two Specific Drug Binding Sites on Human Serum Albumin
- 2)Further Characterization of Specific Drug Binding Sites on Human Serum Albumin
- 3)Fluorescent Dye Cocktail for Multiplex Drug-Site Mapping on Human Serum Albumin
Application
Specific fluorescent probe binding to drug binding site 1 on human serum albumin (HSA)
References
- Drug binding properties of glycosylated human serum albumin as measured by fluorescence and circular dichroism
- A general, wide-rage spectrofluorometric method for measuring the site-specific affinities of drugs toward human serum albumin
- Structural and functional insights into S-thiolation of human serum albumins
- Binding modes of environmental endocrine disruptors to human serum albumin: insights from STD-NMR, ITC, spectroscopic and molecular docking studies
- 8‐Prenylnaringenin tissue distribution and pharmacokinetics in mice and its binding to human serum albumin and cellular uptake in human embryonic kidney cells
考研文獻
TCIMail
[Product Highlights] Fluorescent Probes for the Characterization of Two Specific Drug Binding Sites on HSA[Product Highlights] Fluorescent Probe for Human Serum Albumin (HSA)-Drug Binding Assay
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。
![Dansylamide [for Fluorometry]](/medias/D1507.jpg?context=bWFzdGVyfHJvb3R8Mjc3MjN8aW1hZ2UvanBlZ3xhRGd3TDJnNU55ODVNVGN6T1RZNU5EWTVORGN3TDBReE5UQTNMbXB3Wnd8Yzk1MDNmYmNhZjdjMzJjYTEyNmRlYTk5OWNiMjg0M2RmM2Q1MzNhZmQ4NDRlMjczZjRhNTUxODI1MTYwOTcxYg "Dansylamide [for Fluorometry]")